Cargando…

The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation

Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15....

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Chong-Kun, Kim, Gu-Hwan, Yoo, Han-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276771/
https://www.ncbi.nlm.nih.gov/pubmed/25510779
http://dx.doi.org/10.3349/ymj.2015.56.1.300
_version_ 1782350292576108544
author Cheon, Chong-Kun
Kim, Gu-Hwan
Yoo, Han-Wook
author_facet Cheon, Chong-Kun
Kim, Gu-Hwan
Yoo, Han-Wook
author_sort Cheon, Chong-Kun
collection PubMed
description Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15. Here, we report the case of a 32-day-old Korean male with HDR syndrome. He was presented due to repeated seizures over previous 3 days. The patient was born after 40 weeks of gestation with birth weight of 2930 g, and was the first-born baby of healthy Korean parents. Hypoparathyroidism was first noticed due to seizure. A multicystic left dysplastic kidney and vesicoureteral reflux were detected by ultrasound after birth. Auditory brainstem response (ABR) testing revealed that the patient had moderate sensorineural deafness, with hearing losses of 80 dB at the mid and higher frequencies for both ears. Echocardiography finding revealed secundum atrial septal deftect. Based on biochemical results and clinical findings, a presumptive diagnosis of HDR syndrome was made. GATA3 mutation analysis identified a heterozygous deletion, c.153del (p.Phe51Leufs(*)144) in exon 1 causing a frameshift mutation, which is a novel de novo mutation. Therefore, we suggest that HDR syndrome should be considered in the differential diagnosis in symptomatic or asymptomatic patients with hypoparathyroidism, and that renal ultrasound or ABR testing be performed to prevent a missed diagnosis. This is the first report on Korean patient with confirmed HDR syndrome with novel mutation.
format Online
Article
Text
id pubmed-4276771
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-42767712015-01-01 The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation Cheon, Chong-Kun Kim, Gu-Hwan Yoo, Han-Wook Yonsei Med J Case Report Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15. Here, we report the case of a 32-day-old Korean male with HDR syndrome. He was presented due to repeated seizures over previous 3 days. The patient was born after 40 weeks of gestation with birth weight of 2930 g, and was the first-born baby of healthy Korean parents. Hypoparathyroidism was first noticed due to seizure. A multicystic left dysplastic kidney and vesicoureteral reflux were detected by ultrasound after birth. Auditory brainstem response (ABR) testing revealed that the patient had moderate sensorineural deafness, with hearing losses of 80 dB at the mid and higher frequencies for both ears. Echocardiography finding revealed secundum atrial septal deftect. Based on biochemical results and clinical findings, a presumptive diagnosis of HDR syndrome was made. GATA3 mutation analysis identified a heterozygous deletion, c.153del (p.Phe51Leufs(*)144) in exon 1 causing a frameshift mutation, which is a novel de novo mutation. Therefore, we suggest that HDR syndrome should be considered in the differential diagnosis in symptomatic or asymptomatic patients with hypoparathyroidism, and that renal ultrasound or ABR testing be performed to prevent a missed diagnosis. This is the first report on Korean patient with confirmed HDR syndrome with novel mutation. Yonsei University College of Medicine 2015-01-01 2014-12-10 /pmc/articles/PMC4276771/ /pubmed/25510779 http://dx.doi.org/10.3349/ymj.2015.56.1.300 Text en © Copyright: Yonsei University College of Medicine 2015 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Cheon, Chong-Kun
Kim, Gu-Hwan
Yoo, Han-Wook
The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title_full The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title_fullStr The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title_full_unstemmed The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title_short The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
title_sort first korean case of hdr syndrome confirmed by clinical and molecular investigation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276771/
https://www.ncbi.nlm.nih.gov/pubmed/25510779
http://dx.doi.org/10.3349/ymj.2015.56.1.300
work_keys_str_mv AT cheonchongkun thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation
AT kimguhwan thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation
AT yoohanwook thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation
AT cheonchongkun firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation
AT kimguhwan firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation
AT yoohanwook firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation